Sorry, you need to enable JavaScript to visit this website.
Skip to main content

The TRAVERSE study serves as a pivotal step in providing comprehensive safety data on TRT, especially on testosterone gel, the application form used in this study.1,2

In this study summary you will find out more about the prostate TRAVERSE substudy and how it changed the perception of the safety profile of TRT.3

References: 

1. Bhasin S, et al. Effects of long-term testosterone treatment on cardiovascular outcomes in men with hypogonadism: Rationale and design of the TRAVERSE study. Am Heart J. 2022 Mar;245:41-50.

2. Lincoff AM, et al. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med. 2023 Jul 13;389(2):107-117.

3. Bhasin S, et al. Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial. JAMA Netw Open. 2023;6(12):e2348692.

View PDF